BRAINSTORM CELL THERAPEUTICS INC. Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) reported Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net of $795.00 thousand for the 162-month period ending 2014-03-31, per its 10-Q filed 2014-05-13.
Discontinued › Income Statement › Other Income
us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet · last filed 2014-05-13
- BRAINSTORM CELL THERAPEUTICS INC. derivative instruments not designated as hedging instruments, gain (loss), net for the quarter ending 2014-03-31 was $0.00.
- BRAINSTORM CELL THERAPEUTICS INC. derivative instruments not designated as hedging instruments, gain (loss), net for the quarter ending 2013-12-31 was $0.00.
- BRAINSTORM CELL THERAPEUTICS INC. derivative instruments not designated as hedging instruments, gain (loss), net for the quarter ending 2013-09-30 was $0.00.
- BRAINSTORM CELL THERAPEUTICS INC. derivative instruments not designated as hedging instruments, gain (loss), net for the quarter ending 2013-06-30 was $0.00.
- BRAINSTORM CELL THERAPEUTICS INC. derivative instruments not designated as hedging instruments, gain (loss), net for fiscal 2013 was $0.00.
- BRAINSTORM CELL THERAPEUTICS INC. derivative instruments not designated as hedging instruments, gain (loss), net for fiscal 2012 was $0.00.
| Period end | Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net 3 month | Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net 6 month | Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net 9 month | Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net 12 month | Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net 153 month | Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net 156 month | Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net 159 month | Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net 162 month |
|---|---|---|---|---|---|---|---|---|
| 2014-03-31 | $0.00 derived: 10-Q 162 month − 10-K 159 month · filed 2014-05-13 | $0.00 derived: sum of 2 quarters · filed 2014-05-13 | $0.00 derived: sum of 3 quarters · filed 2014-05-13 | $0.00 derived: sum of 4 quarters · filed 2014-05-13 | $795.00K 10-Q · filed 2014-05-13 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $0.00 derived: sum of 2 quarters · filed 2014-03-27 | $0.00 derived: sum of 3 quarters · filed 2014-03-27 | $0.00 10-K · filed 2014-03-27 | $795.00K 10-K · filed 2014-03-27 | |||
| 2013-09-30 | $0.00 10-Q · filed 2013-11-14 | $0.00 derived: sum of 2 quarters · filed 2013-11-14 | $0.00 10-Q · filed 2013-11-14 | $0.00 derived: sum of 4 quarters · filed 2014-05-13 | $795.00K 10-Q · filed 2013-11-14 | |||
| 2013-06-30 | $0.00 10-Q · filed 2013-08-14 | $0.00 10-Q · filed 2013-08-14 | $0.00 derived: sum of 3 quarters · filed 2014-05-13 | $0.00 derived: sum of 4 quarters · filed 2014-05-13 | $795.00K 10-Q · filed 2013-08-14 | |||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-13 | $0.00 derived: sum of 2 quarters · filed 2014-05-13 | $0.00 derived: sum of 3 quarters · filed 2014-05-13 | $0.00 derived: sum of 4 quarters · filed 2014-05-13 | ||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $0.00 derived: sum of 2 quarters · filed 2014-03-27 | $0.00 derived: sum of 3 quarters · filed 2014-03-27 | $0.00 10-K · filed 2014-03-27 | ||||
| 2012-09-30 | $0.00 10-Q · filed 2013-11-14 | $0.00 derived: sum of 2 quarters · filed 2013-11-14 | $0.00 10-Q · filed 2013-11-14 | |||||
| 2012-06-30 | $0.00 10-Q · filed 2013-08-14 | $0.00 10-Q · filed 2013-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |